Aarti Industries Limited (NSE: AARTIIND | BSE: 524208)

By Raveendran R | Updated on:

Source: Aarti Industries Limited Annual Report FY 2025-26 (Fiscal Year Ended March 31, 2026)

Metrics for FY 2025-26 Ended Mar 31, 2026
Profit & Loss (₹ Cr)
Revenue
₹8,286.10 Cr (▲ 14.0%)
Prev Year: ₹7,269.42 Cr
Gross Profit
₹2,937.00 Cr (▲ 12.3%)
Prev Year: ₹2,614.30 Cr
Operating Profit
₹697.86 Cr (▲ 20.0%)
Prev Year: ₹581.73 Cr
Net Profit
₹419.06 Cr (▲ 26.7%)
Prev Year: ₹330.87 Cr
Ratios & Margins (% / x)
Gross Margin
35.44 % (▼ 52 bps)
Prev Year: 35.96 %
Operating Margin
8.42 % (▲ 42 bps)
Prev Year: 8.00 %
PAT Margin
5.06 % (▲ 51 bps)
Prev Year: 4.55 %
ROCE
8.45 % (▲ 84 bps)
Prev Year: 7.61 %
ROCE (5Y Avg)
13.18 %
FY22–FY26 (5Y Avg)
ROE
7.04 % (▲ 113 bps)
Prev Year: 5.90 %
ROE (5Y Avg)
11.54 %
FY22–FY26 (5Y Avg)
ROA
3.15 % (▲ 17 bps)
Prev Year: 2.98 %
Asset Turnover
0.62x (▼ 0.03 pts)
Prev Year: 0.65x
Balance Sheet (₹ Cr)
Total Assets
₹13,300.23 Cr (▲ 19.7%)
Prev Year: ₹11,113.52 Cr
Current Assets
₹4,187.33 Cr (▲ 44.7%)
Prev Year: ₹2,894.74 Cr
Total Liabilities
₹7,344.95 Cr (▲ 33.3%)
Prev Year: ₹5,508.30 Cr
Current Liabilities
₹5,039.27 Cr (▲ 45.4%)
Prev Year: ₹3,466.40 Cr
Total Debt
₹4,921.00 Cr (▲ 29.9%)
Prev Year: ₹3,789.00 Cr
Total Equity
₹5,955.27 Cr (▲ 6.2%)
Prev Year: ₹5,605.22 Cr
Working Capital
-₹851.94 Cr (▼ 49.0%)
Prev Year: -₹571.66 Cr
Ratios & Margins (% / x)
Current Ratio
0.83x (- 0.00 pts)
Prev Year: 0.84x
Debt to Equity
0.83x (▲ 0.15 pts)
Prev Year: 0.68x
Debt to Assets
0.37x (▲ 0.03 pts)
Prev Year: 0.34x
Equity Multiplier
2.23x (▲ 0.25 pts)
Prev Year: 1.98x
Cash Flow (₹ Cr)
Operating Cash Flow
₹780.80 Cr (▼ 36.9%)
Prev Year: ₹1,237.62 Cr
CapEx
₹2,029.52 Cr (▲ 59.3%)
Prev Year: ₹1,273.80 Cr
Free Cash Flow
-₹1,248.72 Cr (▼ 3351.4%)
Prev Year: -₹36.18 Cr
Ratios & Margins (% / x)
FCF Margin
-15.07 % (▼ 1457 bps)
Prev Year: -0.50 %
Cash ROCE
9.45 % (▼ 673 bps)
Prev Year: 16.18 %
Cash ROE
13.11 % (▼ 897 bps)
Prev Year: 22.08 %
CF to Debt
0.16x (▼ 0.17 pts)
Prev Year: 0.33x

📋 Quick Facts: Company Snapshot

Attribute Disclosed Detail
Official Company Name Aarti Industries Limited
Corporate Identity Number (CIN) L24110GJ1984PLC007301
ISIN INE769A01020
NSE Symbol & BSE Scrip Code NSE: AARTIIND | BSE: 524208
Date of Incorporation / Founding Year 1984 (Incorporated as Aarti Organic Private Limited)
Founders / Key Founding Figures Shri Chandrakant Vallabhaji Gogri (Founder & Chairman Emeritus)
Registered Office Plot Nos. 801, 801/23, G.I.D.C. Estate, Phase-III, Vapi – 396 195, Dist. Valsad, Gujarat, India
Corporate Headquarters 4th Floor, Tower C, Embassy 247 Park, LBS Marg, Gandhi Nagar, Vikhroli West, Mumbai – 400 083, Maharashtra, India
Telephone & Investor Relations Contact Tel: +91 22 69436100 | Email: investorrelations@aarti-industries.com / info@aarti-industries.com
Chairman & Managing Director Shri Rajendra V. Gogri (Chairman & Managing Director; transitioning to Non-Executive Chairman w.e.f. October 1, 2026)
CEO & Executive Director Shri Suyog K. Kotecha (CEO & Executive Director; appointed Managing Director w.e.f. October 1, 2026)
Chief Financial Officer & Company Secretary Shri Chetan Gandhi (CFO & Chief Risk Officer) | Shri Raj Sarraf (Company Secretary & Chief Compliance Officer)
Promoter & Holding Group Gogri Family / Promoter Group (42.09% equity holding as of March 31, 2026)
Industry / Sector Classification Specialty Chemicals, Intermediates & Basic Chemicals
Workforce Strength (BRSR Disclosed) 5,824 Permanent Employees; 2,286 Non-Worker Employees; 3,538 Permanent Workers; 7,259 Contract/Other Workers
Manufacturing Infrastructure 16 Manufacturing Plants across Vapi, Tarapur, Jhagadia, Dahej, Kutch (Anushakti), Gujarat & Maharashtra; 4 R&D Centres (incl. 2 Pilot Plants)
Geographic Reach 400+ International Customers across 60+ Countries; 700+ Domestic Customers across India
Statutory Auditors M/s Gokhale & Sathe, Chartered Accountants (Firm Regn. No. 103264W)
Secretarial Auditors M/s BNP & Associates, Company Secretaries (Firm Regn. No. P2014MH037400)
Registrar & Share Transfer Agent (RTA) MUFG Intime India Private Limited (Formerly Link Intime India Private Limited), C-101, 247 Park, LBS Marg, Vikhroli (W), Mumbai – 400 083

🏢 The Corporate Identity: Aarti Industries Limited Overview, Promoters & History

The Big Picture: Business Model & Core Value Proposition

Aarti Industries Limited (AIL) is a globally recognised, integrated specialty chemicals manufacturer anchored in benzene, toluene, and sulphuric acid value chains. Operating through 16 state-of-the-art manufacturing facilities and 4 specialized R&D centers across Western India, AIL has evolved from a traditional chemical manufacturer into a platform-led integrated chemistry solution provider. The Company commands a dominant market presence, ranking among the top three global manufacturers for over 75% of its core product portfolio, including global leadership in Di-Chloro Benzene (DCB) and top-tier rankings in Hydrogenation, Chlorination, Nitration, and Nitro Chloro Benzene (NCB) derivative value chains.

AIL’s business model relies on deep backward and forward integration, combining scalable process engineering with strategic customer co-development. Serving 1,100+ customers across 60+ countries, the Company delivers tailored chemistry solutions to critical end-use sectors including agrochemicals, high-performance polymers, pharmaceuticals, energy fuel additives, printing inks, dyes, pigments, and advanced electronics materials. AIL’s competitive moat is reinforced by continuous multi-step chemistry mastery, high asset uptime, long-term multi-year customer off-take agreements, and robust Zero Liquid Discharge (ZLD) environmental infrastructure across 11 manufacturing units.

  • Global Manufacturing Leadership: Globally ranked #1 in Di-Chloro Benzene (DCB) and among the top 2-3 global players in Hydrogenation, Nitration, Chlorination, and Nitro Chloro Benzene (NCB).
  • Integrated Value Chain Focus: Comprehensive process control over Benzene, Toluene, and Sulphuric Acid derivative chains, enabling structural cost efficiency, total product traceability, and high operational reliability.
  • Long-Term Strategic Partnerships: Backed by multi-year commercial contracts, including a landmark USD 150 million agrochemical intermediate agreement and a 15-year backward integration framework with a global chemical major.
  • Future-Ready Specialty Platforms: Expanding into Zone IV greenfield multi-purpose plants at Jhagadia, advanced fluorination, photochlorination, electronic chemicals, and battery materials for EV applications.

The Founders, Promoters & Their Legacy

The enterprise was founded in 1984 by first-generation technocrats led by Shri Chandrakant Vallabhaji Gogri, a Chemical Engineering alumnus from the Institute of Chemical Technology (ICT, formerly UDCT), Mumbai. Under his visionary stewardship, the Company transformed from a modest single 1,200 TPA NCB unit in Sarigam into a globally respected specialty chemicals major. Shri Chandrakant V. Gogri served as Founding Chairman until 2012 and continues to guide the enterprise as Chairman Emeritus, bringing institutional wisdom, strategic vision, and deep technical domain expertise.

The Promoter Group maintains an active stewardship model through executive and non-executive leadership. Chairman and Managing Director Shri Rajendra V. Gogri and Vice Chairmen Shri Rashesh C. Gogri and Shri Renil R. Gogri have spearheaded AIL’s multi-decadal expansion, technological absorption, and international market penetration. To further institutionalize corporate governance, AIL announced a planned leadership transition effective October 01, 2026. Under this governance evolution, professional management led by CEO Shri Suyog K. Kotecha (appointed Managing Director w.e.f. October 01, 2026) will handle day-to-day executive operations, while Promoter Directors transition to Non-Executive Board roles to focus on long-term strategy, capital allocation, and governance oversight.

The Journey: Corporate History & Key Milestones

AIL’s growth journey spans four decades of continuous capability building, process intensification, and strategic global integration:

  • 1984–1995 (Foundational Era): Incorporated as Aarti Organic Private Limited in 1984; commissioned first 1,200 TPA NCB plant in Sarigam (1986); established large-scale 4,500 TPA NCB facility in Vapi (1990); listed on BSE and NSE in 1992 and 1995 respectively.
  • 1997–2012 (Scale & Global Integration): Established hydrogenation and nitration units at Jhagadia (1997-99); received USFDA approval for Custom Synthesis division in Vapi (2004-08); continuous process upgrades in hydrogenation; expanded NCB capacity to 75 KTPA.
  • 2013–2018 (Portfolio Diversification): Merged Anushakti Chemicals; commissioned ethylation facility at Dahej SEZ (2014); scaled NCB capacity to 75 KTPA; commissioned Calcium Chloride, co-generation, and solar power plants; signed initial global multi-year contracts.
  • 2019–2026 (Specialty & Innovation Focus): Executed multiple multi-year contracts; operationalized Aarti Research & Technology Centre (ARTC) in Navi Mumbai; scaled NCB capacity to 108 KTPA; completed Phase 1 Dahej SEZ and Chlorination units; commissioned Zone IV pilot plant and Acid Revamp; formed 50:50 Joint Venture Augene Chemical with Superform Chemistries (UPL group) and circular recycling JV Re Aarti with Re Sustainability; secured USD 150 million multi-year global agrochemical supply agreement in FY26.

The Corporate Umbrella & Group Structure

Aarti Industries Limited operates an integrated corporate structure comprising seven direct subsidiaries, two step-down subsidiaries, and two strategic joint ventures. These entities support dedicated logistics, international sales, specialized chemical manufacturing, and environmental circularity platforms.

The corporate family tree includes Aarti Corporate Services Limited, Aarti Polychem Private Limited, Aarti Bharuch Limited, Aarti Circularity Limited, Innovative Envirocare Jhagadia Limited, Alchemie (Europe) Limited (UK), and Aarti Chemical Trading FZCO (Dubai, UAE) alongside step-down arms Shanti Intermediates Private Limited and Aarti Chem Trading USA Inc. On the joint venture front, AIL holds a 50% equity stake in Augene Chemical Private Limited (partnered with Superform Chemistries Limited) for specialty agrochemical/paint intermediates, and a 49% stake in Re Aarti Private Limited (partnered via Aarti Circularity with Re Sustainability Limited) to drive chemical recycling of plastic materials across India.

⚙️ The Business Engine: Segments, Brands, Products & Operations

The Core Divisions & Segment Revenue Breakdown

Aarti Industries Limited operates primarily within a unified corporate operating segment dedicated to Specialty Chemicals, Intermediates, and Basic Chemicals under Ind AS 108. Internally, management tracks revenue diversification across key global end-use market categories. During FY 2025-26, total gross revenue from operations reached ₹ 9,018.43 Crores, representing a 12.11% year-on-year expansion compared to ₹ 8,044.11 Crores in FY 2024-25, driven by a 30%+ volume growth in core specialty products and steady domestic/export demand recovery.

End-Use Application Segment FY 2025-26 Revenue Share (%) FY 2024-25 Revenue Share (%) Key Drivers & Operational Trends
Energy (Fuel Additives / MMA) 43% 36% Highest-ever volumes in Methyl Aniline (MMA); scaling fuel additive capacities from 290 KTPA to 360 KTPA.
Agrochemicals & Fertilisers 18% 18% Stable demand for PNCB and intermediates; bolstered by USD 150 million multi-year global supply contract.
Polymers & Additives 14% 15% Strong traction in DCB expansion (120 to 140 KTPA) linked to high-growth EV battery and PPS polymer applications.
Dyes, Pigments & Printing Inks 11% 12% Resilient domestic off-take; stable volume performance across PDA and nitrotoluene derivatives.
Pharmaceuticals 10% 10% Steady demand for MNCB, MDCB, and fluorinated intermediates; expanding CDMO pipeline at ARTC.
Others (Basic Chemicals / Industrial) 4% 9% Custom synthesis, basic sulphuric acid derivatives, and specialized industrial intermediates.

The Product & Service Catalog (with Operational KPIs & Order Book)

AIL’s commercial catalog spans over 100 specialty chemical products serving 400+ downstream industrial applications. The chemistry platforms leverage nitration, chlorination, hydrogenation, ethylation, ammonolysis, halogenation, diazotisation, methoxylation, and photochlorination processes. Key process chains include:

  • Benzene Value Chain: Nitro Chloro Benzene (NCB – Mono/Para/Ortho), Di-Chloro Benzene (DCB – Para/Ortho/Meta), Phenylenediamines (PDA), Hydrogenated derivatives, and Nitro Fluoro Aromatics via Halex chemistry.
  • Toluene Value Chain: Nitrotoluene (PNT/ONT/MNT), Toluidines, Dichlorotoluene, and photochlorinated downstream intermediates for specialty herbicides and engineering polymers.
  • Sulphuric Acid Value Chain: Sulphuric Acid, Oleum (23/32/65), Chlorosulphonic Acid (CSA), and Dimethyl Sulphate (DMS), supporting internal captal consumption and regional industrial supply.
  • Energy & Polymer Additives: Monomethyl Aniline (MMA), Dimethyl Aniline (DMA), PCBTF (Parachlorobenzotrifluoride for low-VOC coatings), and high-purity monomer additives.

Operational KPIs for FY 2025-26 demonstrate substantial physical throughput expansion: Total production volume reached 12,27,645 MT (up 19% YoY across key product lines). Capacity utilization improved to approximately 80% across major product blocks. NCB capacity stands scaled at 108 KTPA, Nitrotoluene at 45 KTPA, MMA capacity scaled to 290 KTPA (targeting 360 KTPA), and DCB capacity expanding from 120 KTPA to 140 KTPA to capture EV-linked Polyphenylene Sulfide (PPS) market growth.

The Names You Know: Key Brands & Flagship Portfolio

Brand / Product Name Category / Business Segment Target Market & Key Positioning
Nitro Chloro Benzene (PNCB / ONCB) Agrochemicals & Pharma Intermediates Global benchmark feedstock for active pharmaceutical ingredients (APIs), crop protection, and dyestuff.
Para-Dichlorobenzene (PDCB) & ODCB Polymers & High-Performance Materials Key building block for PPS plastics used in EV battery housings, automotive lightweighting, and electronics.
Monomethyl Aniline (MMA) Energy & Fuel Additives High-octane booster additive for global fuel refining and energy applications.
PCBTF (Parachlorobenzotrifluoride) Paints & Functional Coatings Exclusively distributed via Actylis in North America as an eco-friendly, low-VOC solvent for industrial coatings.
Phenylenediamines (p-PDA / o-PDA) Dyes, Pigments & Specialty Polymers Essential intermediate for aramid fibers, high-grade pigments, rubber chemicals, and engineering plastics.

Mapping the Domestic & Global Reach (India vs. Exports)

AIL maintains a balanced revenue distribution across Indian domestic markets and high-growth export corridors. Exports accounted for 57% of total revenues in FY 2025-26 (₹ 5,043.88 Crores on a consolidated gross basis), while domestic sales represented 43% (₹ 3,974.55 Crores).

Geographic Region FY 2025-26 Revenue Contribution (%) Key Strategic Markets & Operations
India (Domestic) 43% Primary supplier to domestic agrochemical, pharma, dye, and polymer hubs across Gujarat, Maharashtra, and North India.
Europe 25% Strong off-take in agrochemical and pharma intermediates; supported by Alchemie (Europe) Limited.
North America 11% Expanding reach in coatings (PCBTF) and energy sectors; supported by Aarti Chem Trading USA Inc.
Middle East 9% Energy sector additives, fuel refining chemicals, and industrial intermediates; supported by Aarti Chemical Trading FZCO.
Rest of Asia 6% Specialty intermediates for electronics, agrochemicals, and industrial polymers across East and SE Asia.
Rest of the World (RoW) 6% Latin America, Africa, and global emerging specialty chemical demand centers.

The Brick & Mortar Footprint: Manufacturing Plants, R&D & Offices

AIL operates 16 manufacturing plants and 4 R&D/Pilot assets strategically clustered in Western India near key maritime export ports (Jawaharlal Nehru Port Trust, Hazira, and Mundra):

  • Vapi Division (Gujarat): Multi-facility hub comprising Acid Division (Fertiliser, DMS, Oleum), Amine Division, Alchemie Division, Organic Division, Nascent Division, and the Apple Division Pilot Plant. Features Zero Liquid Discharge (ZLD) plants and continuous nitration/hydrogenation process blocks.
  • Jhagadia Site (Gujarat): Mega-site featuring Pearl, Ruby, Jade, and Gold divisions, alongside the flagship Zone IV Greenfield Complex. Zone IV anchors multi-purpose plants (MPP), 4,000 TPA PEDA facility, Calcium Chloride unit, and chlorotoluene expansion.
  • Dahej SEZ & Industrial Complex (Gujarat): Houses Neo, Diamond, and Saffron divisions, hosting world-scale Ethylation units (25-30 KTPA), Chlorination units, and export-oriented specialty production blocks.
  • Kutch Site (Anushakti & Urja Divisions, Gujarat): Specialized nitration, chlorination, and power infrastructure site located in Kutch.
  • Tarapur Site (Topaz Division, Maharashtra): Specialized manufacturing facility serving regional pharma and industrial intermediate markets.
  • R&D & Innovation Infrastructure: Anchored by the state-of-the-art Aarti Research & Technology Centre (ARTC) in Navi Mumbai (250+ scientists, NABL/ISO 27001 certified, process safety labs) and 2 specialized pilot plants (Apple division Vapi and Zone IV Jhagadia).
  • Corporate Offices: Corporate Headquarters at Embassy 247 Park, Vikhroli (West), Mumbai; Registered Office in Vapi, Gujarat; Satellite Office in Vadodara, Gujarat.

📊 The Financial Health: The Numbers Simplified

Multi-Year Financial Highlights (₹ in Crores)

Financial Metric FY 2025-26 FY 2024-25 FY 2023-24 FY 2022-23 FY 2021-22 Latest YoY (%)
Gross Income from Operations 9,018 8,044 7,012 7,283 6,871 +12.11%
Operating EBITDA 1,172 1,016 984 1,089 1,720 +15.35%
Finance Costs / Interest 340 275 211 168 102 +23.64%
Depreciation & Amortisation 474 434 378 310 246 +9.22%
Profit Before Tax (PBT) 365 307 395 611 1,372 +18.89%
Profit After Tax (PAT) 419.06 330.87 416 545 1,166 +26.65%
Equity Share Capital 181.30 181.26 181.25 181.25 181.25 +0.02%
Total Equity / Net Worth 5,955 5,605 5,290 4,921 4,517 +6.24%
Total Debt (Long & Short Term) 4,921 3,789 3,184 2,874 2,568 +29.88%
Gross Fixed Assets 8,932 8,429 7,292 6,335 5,083 +5.97%
Capital Work in Progress (CWIP) 2,187 1,454 1,229 1,096 1,346 +50.41%
Basic EPS (₹) 11.56 9.13 11.49 15.04 32.71 +26.62%
Debt to Equity Ratio (x) 0.72 0.62 0.60 0.58 0.57 +16.13%
Return on Net Worth (RONW %) 7.2% 6.1% 8.1% 11.5% 29.5% –

Earnings, Expenses, & Take-Home Profits (Consolidated Profit & Loss)

During FY 2025-26, AIL generated Gross Revenue from Operations of ₹ 9,018.43 Crores (Net Revenue of ₹ 8,286.10 Crores after GST collection of ₹ 732.33 Crores), expanding 12.11% YoY. Operating EBITDA grew 13.99% YoY to ₹ 1,172.00 Crores (or ₹ 1,168.00 Crores on a net P&L basis), reflecting operational leverage, improved asset utilization (~80%), and structural cost-optimisation benefits under Project UNNATI and Project Aarohan. Profit After Tax (PAT) registered a robust 26.65% growth to ₹ 419.06 Crores despite mark-to-market forex adjustments, inventory corrections in Q1, and a one-time non-recurring labor code compliance charge of ₹ 15.37 Crores.

Consolidated Statement of Profit & Loss Line Item FY 2025-26 (₹ in Crores) FY 2024-25 (₹ in Crores) Latest YoY (%)
Gross Revenue from Operations 9,018.43 8,044.11 +12.11%
Less: GST Collected 732.33 774.69 -5.47%
Net Revenue from Operations 8,286.10 7,269.42 +13.99%
Other Income 4.87 17.52 -72.20%
Total Income 8,290.97 7,286.94 +13.78%
Cost of Materials Consumed (incl. Packing, Fuel, Stores & Spares) 5,256.50 4,381.36 +19.97%
Purchases of Stock-in-Trade 600.40 219.73 +173.24%
Changes in Inventories of Finished Goods, WIP & Stock-in-Trade (507.80) 54.03 N/M
Employee Benefits Expense 422.14 447.11 -5.58%
Finance Costs 339.93 275.44 +23.41%
Depreciation and Amortisation Expenses 474.14 434.27 +9.18%
Foreign Exchange (Gain) / Loss (16.27) 3.35 N/M
Other Expenses 1,363.56 1,166.74 +16.87%
Total Expenses 7,932.60 6,982.02 +13.61%
Profit Before Tax & Exceptional Items 358.37 304.92 +17.53%
Exceptional Items (Net) 6.46 2.37 +172.57%
Profit Before Tax (PBT) 364.83 307.29 +18.72%
Total Tax Expenses (54.34) (23.64) +129.86%
Profit After Tax before Share of JV / Non-Controlling Interest 419.18 330.92 +26.67%
Share of Profit / (Loss) of Joint Ventures (0.12) (0.06) +100.00%
Net Profit for the Year (PAT Attributable to Equity Holders) 419.06 330.87 +26.65%
Other Comprehensive Income (Net of Tax) (42.34) 14.22 N/M
Total Comprehensive Income for the Year 376.72 345.09 +9.17%
Basic Earnings Per Share (₹) 11.56 9.13 +26.62%
Diluted Earnings Per Share (₹) 11.55 9.12 +26.64%

Assets, Borrowings, & Net Worth (Consolidated Balance Sheet)

As of March 31, 2026, AIL’s Consolidated Balance Sheet expanded to ₹ 13,300.23 Crores, compared to ₹ 11,113.52 Crores in FY 2024-25. Total Equity (Net Worth) stood strengthened at ₹ 5,955.27 Crores. Gross Fixed Assets reached ₹ 8,932 Crores, with Net Property, Plant and Equipment at ₹ 6,264.89 Crores. Capital Work-in-Progress (CWIP) rose to ₹ 2,029.52 Crores, reflecting peak execution across the Jhagadia Zone IV greenfield facilities, MMA capacity expansion, and ethylation value chains.

Consolidated Balance Sheet Schedule III Line Item As at March 31, 2026 (₹ in Crores) As at March 31, 2025 (₹ in Crores) Latest YoY (%)
ASSETS: Non-Current Assets
Property, Plant and Equipment 6,264.89 6,277.48 -0.20%
Capital Work-in-Progress (CWIP) 2,029.52 1,273.80 +59.33%
Right of Use Assets 37.48 51.06 -26.60%
Intangible Assets 96.72 48.25 +100.46%
Intangible Assets under Development 157.48 180.41 -12.71%
Non-Current Investments 132.34 47.63 +177.85%
Non-Current Loans & Advances 10.45 0.06 +17316.67%
Deferred Tax Assets (Net & incl. MAT Credit) 304.41 217.99 +39.64%
Other Non-Current Assets 79.61 122.10 -34.80%
Total Non-Current Assets 9,112.89 8,218.78 +10.88%
ASSETS: Current Assets
Inventories 1,732.17 1,454.02 +19.13%
Trade Receivables 1,402.90 786.06 +78.47%
Cash and Cash Equivalents 582.73 199.39 +192.26%
Bank Balances other than Cash & Cash Equivalents 25.74 95.58 -73.07%
Current Loans and Advances 4.82 6.27 -23.13%
Other Current Financial Assets 57.94 16.32 +255.02%
Current Tax Assets (Net) 13.28 13.89 -4.39%
Other Current Assets 367.75 323.21 +13.78%
Total Current Assets 4,187.33 2,894.74 +44.65%
TOTAL ASSETS 13,300.23 11,113.52 +19.68%
EQUITY AND LIABILITIES: Equity
Equity Share Capital 181.30 181.26 +0.02%
Other Equity 5,773.87 5,423.86 +6.45%
Non-Controlling Interest 0.10 0.10 0.00%
Total Equity (Net Worth) 5,955.27 5,605.22 +6.25%
EQUITY AND LIABILITIES: Non-Current Liabilities
Non-Current Borrowings 2,187.72 1,867.42 +17.15%
Non-Current Lease Liabilities 33.98 47.13 -27.90%
Other Non-Current Liabilities 69.83 112.16 -37.74%
Non-Current Provisions 14.16 15.19 -6.78%
Total Non-Current Liabilities 2,305.68 2,041.90 +12.92%
EQUITY AND LIABILITIES: Current Liabilities
Current Borrowings 2,733.28 1,922.13 +42.20%
Current Lease Liabilities 11.35 11.11 +2.16%
Trade Payables (Micro & Small Enterprises) 57.15 26.48 +115.82%
Trade Payables (Other than Micro & Small) 1,783.48 1,211.00 +47.27%
Other Current Financial Liabilities 370.01 202.51 +82.71%
Other Current Liabilities 69.31 77.25 -10.28%
Current Provisions 14.69 15.91 -7.67%
Total Current Liabilities 5,039.27 3,466.40 +45.37%
Total Liabilities 7,344.95 5,508.30 +33.34%
TOTAL EQUITY AND LIABILITIES 13,300.23 11,113.52 +19.68%

Cash Flow: Tracking the Money Movement

AIL generated strong operating cash flows of ₹ 780.80 Crores in FY 2025-26 (compared to ₹ 1,237.62 Crores in FY 2024-25), demonstrating resilient cash generation despite working capital absorption driven by revenue growth and raw material inventory buildup. Capital expenditure outlay (Purchase of Property, Plant & Equipment / CWIP) reached ₹ 1,124.28 Crores as the multi-year Zone IV investment cycle reached its peak. Financing cash inflows stood at ₹ 744.63 Crores, driven by long-term debt drawdowns to fund greenfield projects, while dividend payments totaled ₹ 36.26 Crores.

Consolidated Cash Flow Statement Summary FY 2025-26 (₹ in Crores) FY 2024-25 (₹ in Crores) Latest YoY (%)
Net Profit Before Tax and Exceptional Items 358.37 304.86 +17.55%
Operating Profit Before Working Capital Changes 1,186.80 1,023.31 +15.98%
Net Cash Generated from Operating Activities (A) 780.80 1,237.62 -36.91%
Purchase of Property, Plant and Equipment / CWIP (CapEx) 2,029.52 1,273.80 +59.33%
Proceeds from Sale of Property, Plant & Equipment 8.45% 7.61% –
Other Investing Activities (Investments, Bank Deposits, Interest) (20.93) (18.56) +12.77%
Net Cash Used in Investing Activities (B) (1,142.10) (1,393.35) -18.03%
Proceeds / (Repayment) of Long-Term Borrowings (Net) 8.45% 7.61% –
Proceeds / (Repayment) of Short-Term Borrowings (Net) 8.45% 7.61% –
Finance Costs Paid (217.27) (275.44) -21.12%
Dividends Paid to Equity Shareholders (36.26) (36.25) +0.03%
Principal Repayment of Lease Liabilities & Others (10.64) (9.97) +6.72%
Net Cash Generated from / (Used in) Financing Activities (C) 744.63 (73.17) N/M
Net Increase / (Decrease) in Cash & Cash Equivalents (A+B+C) 383.33 (228.90) N/M
Cash and Cash Equivalents at Beginning of Year 199.39 428.29 -53.45%
Cash and Cash Equivalents at End of Year 582.73 199.39 +192.26%

Funding the Future: CapEx, CWIP & R&D Spending

AIL’s capital allocation strategy is transitioning from a high-intensity capital expenditure cycle towards asset monetization and operational optimization. FY 2025-26 marked the peak of the multi-year investment cycle with capital expenditure of ₹ 1,125 Crores, primarily directed towards the flagship Zone IV Greenfield Complex at Jhagadia, MMA capacity expansion to 290 KTPA, ethylation expansions, and backward integration projects. For FY 2026-27, management expects capital outlays to moderate to ₹ 750–800 Crores, focusing on completing Zone IV blocks, contract-linked customer projects, and routine plant maintenance.

Research & Development serves as the key technology driver for value creation. Total R&D expenditure in FY 2025-26 stood at ₹ 52.14 Crores (comprising ₹ 29.99 Crores in revenue R&D expenditure and ₹ 22.15 Crores in capital R&D investments), compared to ₹ 20.52 Crores in FY 2024-25. Guided by 250+ scientists and 200+ engineers at ARTC Navi Mumbai, AIL maintains an active pipeline of 60+ specialty molecules, focusing on green chemistry, process flow reactors, plastic waste pyrolysis, carbon capture, and battery materials.

👥 Power & Control: Corporate Governance, Leadership & Ownership

The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)

AIL’s Board of Directors comprises 14 eminent professionals, maintaining a balanced 50% independent director representation alongside specialized professional executive management. The Board incorporates two Women Directors (14.29% gender representation).

Name of Director / KMP Designation / Role DIN Category
Shri Rajendra V. Gogri Chairman and Managing Director 00061003 Promoter / Executive Director (Transitioning to Non-Exec w.e.f. Oct 1, 2026)
Shri Rashesh C. Gogri Vice Chairman and Managing Director 00066291 Promoter / Executive Director (Transitioning to Non-Exec w.e.f. Oct 1, 2026)
Shri Renil R. Gogri Vice Chairman and Executive Director 01582147 Promoter / Executive Director (Transitioning to Non-Exec w.e.f. Oct 1, 2026)
Shri Suyog K. Kotecha CEO & Executive Director 10634964 Professional Executive (Appointed Managing Director w.e.f. Oct 1, 2026)
Shri Manoj M. Chheda Executive Director & Chief Manufacturing Officer 00022699 Executive Director
Shri Ajay Kumar Gupta Executive Director & Chief Marketing Officer 08619902 Executive Director
Smt. Hetal Gogri Gala Non-Executive Director 00005499 Promoter Group / Non-Executive Non-Independent
Shri Lalitkumar S. Naik Independent Director 02943588 Independent Non-Executive Director
Prof. Aniruddha B. Pandit Independent Director 02471158 Independent Non-Executive Director
Shri Shekhar S. Khanolkar Independent Director 02202839 Independent Non-Executive Director
Shri Belur K. Sethuram Independent Director 03498701 Independent Non-Executive Director
Shri Nikhil J. Bhatia Independent Director 00414281 Independent Non-Executive Director
Shri Ashok Kumar Barat Independent Director 00492930 Independent Non-Executive Director
Smt. Rupa Devi Singh Independent Director 02191943 Independent Non-Executive Director
Shri Chetan Gandhi Chief Financial Officer & Chief Risk Officer – Key Managerial Personnel
Shri Raj Sarraf Company Secretary & Chief Compliance Officer – Key Managerial Personnel

Who Owns the Stock? Shareholding Pattern

AIL’s shareholding pattern reflects strong promoter stability coupled with significant institutional depth from leading domestic mutual funds, insurance majors, and foreign portfolio investors across a total investor base of 3,84,210 shareholders as of March 31, 2026.

Shareholder Category Number of Equity Shares Held Percentage of Total Voting Rights (%)
Promoter and Promoter Group 15,26,23,660 42.09%
Public – Individuals (Retail Shareholders) 9,35,56,732 25.80%
Mutual Funds 4,17,19,384 11.51%
Insurance Companies (incl. LIC of India – 6.80%) 2,94,54,794 8.12%
Foreign Portfolio Investors (FPIs / FIIs) 2,67,77,096 7.38%
Bodies Corporate 33,84,125 0.93%
Others (Trusts, HUFs, NRIs, Clearing Members) 1,50,78,578 4.15%
Total Equity Share Capital 36,25,94,369 100.00%

🗺️ The Corporate Family Tree: Group Structure & Strategic Investments

Subsidiaries, Associates, & Joint Ventures (Form AOC-1)

AIL’s financial disclosures under Form AOC-1 detail the operational performance and net worth contributions of its corporate entities as of March 31, 2026:

Entity Name Relationship Type Country Group Shareholding (%) Total Revenue (₹ in Crs) Profit / (Loss) After Tax (₹ in Crs)
Aarti Corporate Services Limited Direct Subsidiary India 100.00% 0.12 (0.50)
Innovative Envirocare Jhagadia Limited Direct Subsidiary India 100.00% 0.00 (0.01)
Aarti Polychem Private Limited Direct Subsidiary India 100.00% 0.00 (0.01)
Aarti Bharuch Limited Direct Subsidiary India 100.00% 1.22 (3.35)
Aarti Circularity Limited Direct Subsidiary India 100.00% 0.41 0.34
Alchemie (Europe) Limited Direct Subsidiary United Kingdom 88.89% 8.81 (1.57)
Aarti Chemical Trading FZCO Direct Subsidiary UAE 100.00% 0.38 (0.00)
Shanti Intermediates Private Limited Step-Down Subsidiary (via ACSL) India 100.00% 45.43 (0.28)
Aarti Chem Trading USA Inc. Step-Down Subsidiary (via FZCO) USA 100.00% 39.99 0.34
Augene Chemical Private Limited Joint Venture (50:50 Superform) India 50.00% 977.01 8.40 (Group Share: -0.16)
Re Aarti Private Limited Joint Venture (via Aarti Circularity) India 49.00% 7.58 0.05 (Group Share: +0.03)

Strategic Investments & Treasury Holdings

AIL maintains non-current strategic investments totaling ₹ 132.34 Crores as of March 31, 2026 (compared to ₹ 47.63 Crores in FY 2024-25). Key strategic holdings include ₹ 37.32 Crores equity investment and ₹ 50.88 Crores in Optionally Convertible Debentures (OCDs) in joint venture Augene Chemical Private Limited, ₹ 16.71 Crores in Clean Max Indus Private Limited for renewable power sourcing, ₹ 12.86 Crores in ReNew Green (GJ Six) Private Limited, and ₹ 3.58 Crores in Pro-Zeal Green Power Seven Private Limited for group captive hybrid solar-wind energy access. Quoted equity holdings measured at FVTOCI include stakes in Valiant Organics Limited (₹ 2.11 Crores).

🎯 The Strategic Outlook: Competitive Moats, Risks & Future Growth Plans

Competitive Advantages & Economic Moats

AIL’s industry standing is anchored in structural competitive advantages that create steep barriers to entry:

  • Fully Integrated Process Engineering Platforms: Complete backward and forward integration across Benzene, Toluene, and Sulphuric Acid value chains enables optimal yield recovery, multi-product co-product balancing, and low unit costs.
  • Multi-Purpose Asset Flexibility: Advanced multi-purpose plants (MPP) at Jhagadia Zone IV can handle 34+ complex chemistries, allowing rapid product campaigns and faster lab-to-commercial scale-ups.
  • Proprietary Process Chemistry & Scale-Up Expertise: Over 40 years of mastery in continuous nitration, hydrogenation, photochlorination, halex fluorination, and ethylation supported by 250+ scientists at ARTC.
  • Long-Term Multi-Year Off-Take Frameworks: Deep customer stickiness reinforced by long-term supply agreements with global MNCs, providing revenue predictability and stable margins across business cycles.
  • Sustainability & ESG Leadership: EcoVadis Platinum Rating (top 1% globally), S&P Global Sustainability Yearbook inclusion (CSA Score 78), CDP Leadership Band ratings, and 11 Zero Liquid Discharge (ZLD) plants provide a distinct competitive advantage as MNCs seek compliant global supply partners.

What Could Go Wrong? Key Challenges & Business Risks

Management actively monitors key operational, commercial, and strategic risks under its Enterprise Risk Management (ERM) framework:

  • Global Overcapacity & Chinese Dumping Pressures: Structural excess capacity and aggressive pricing policies from Chinese chemical exporters continue to exert pressure on global spot margins in basic intermediates.
  • Raw Material Price Volatility: Sharp price swings in upstream crude oil and refinery derivatives (Benzene, Aniline, Sulphur, Methanol) can cause short-term inventory valuation adjustments and working capital fluctuations.
  • Geopolitical & Tariff Uncertainties: Evolving trade policies, non-tariff barriers, US tariff adjustments, and potential European Carbon Border Adjustment Mechanism (CBAM) implementations require continuous trade route realignments.
  • Capital Execution & Monetisation Risks: Ensuring timely commercial ramp-up and asset turn optimization across newly commissioned Zone IV greenfield multi-purpose blocks.
  • Environmental & Process Safety Exposures: Managing chemical handling, hazardous waste management, and process safety risks across 16 operating units through continuous Barrier Management and HAZOP/LOPA protocols.

The Next Chapter: Growth, Order Pipeline & CapEx Initiatives

AIL’s growth roadmap focuses on transitioning from capital-led capacity creation to high-margin asset monetization, process intensification, and strategic customer partnerships:

  • Monetising Zone IV Jhagadia: Phased commercialisation of multi-purpose process blocks, chlorotoluene derivatives, 4,000 TPA PEDA facility, and Calcium Chloride units to drive high-margin growth from FY 2026-27 onward.
  • Scaling High-Growth Specialty Niches: Expanding DCB capacity to 140 KTPA to capture EV-linked PPS polymer demand; scaling fuel additive (MMA) capacities to 360 KTPA; advancing custom synthesis (CDMO) contracts at ARTC.
  • Joint Venture Expansion: Commissioning the Augene Chemical JV with Superform Chemistries in FY 2026-27 for paints and agrochemical intermediates; scaling the Re Aarti circular plastics pyrolysis platform to 500 TPD capacity.
  • Decarbonisation & Renewable Integration: Commissioning Phase II 25.7 MW group captive hybrid renewable energy portfolio to exceed 75% renewable power sourcing by FY 2026-27, structurally lowering baseline utility costs and carbon intensity.

The Verdict: Strategic Outlook & Conclusion

Aarti Industries Limited has established a resilient platform, successfully navigating cyclical headwinds, macro uncertainties, and global trade realignment. With gross revenues reaching ₹ 9,018 Crores, EBITDA expanding to ₹ 1,172 Crores, and a strong balance sheet supported by ₹ 5,955 Crores in net worth, the Company is positioned to monetize its multi-year capital investment cycle. Guided by its core values of Care, Integrity, and Excellence, and supported by a seamless leadership transition towards professional management, AIL continues to reinforce its standing as a Global Partner of Choice in specialty chemicals.

Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.

Official Site: https://www.aarti-industries.com

Note: Percentage shares, historical margin trends, and ratio analyses presented in narrative sections were calculated based on financial data disclosed in the Aarti Industries Limited Annual Report FY 2025-26.